Table 1.
Name * | Donor | λem § | Acceptor | λem § | Substrate | Advantages | Drawbacks | Refs |
---|---|---|---|---|---|---|---|---|
BRET 1 | RLuc/RLuc8 | 480 | eYFP | 530 | CLZN h | Monitor PPI at endogenous expression levels of protein RLuc8 more stable than RLuc | Sensitive to solvent polarity, serum and pH | [13,14] |
BRET 1 1.1 | RLuc/RLuc8 | 480 | Venus | 530 | CLZN h | Venus has faster and more efficient maturation compared to YFP Working distance range increased (2.7–8.3 nm) compared to BRET 1 (2.2–6.6 nm) |
[13,15] | |
BRET 1 2 | RLuc | 480 | eYFP | 530 | Enduren | Monitoring of PPI several hours in real-time under near-physiological conditions | Requires expensive Enduren | [15,16] |
BRET 1 3 | RLuc8 | 480 | mOrange | 564 | CLZN h | Application for BRET imaging Wide spectral separation Δλ: 84 nm |
mOrange: slow maturation processes (t1/2: 2 h) |
[17] |
BRET 1 3.1 | RLuc8 | 515 | mOrange | 564 | CLZN v | CLZN v increases the spectral overlap between donor emission and acceptor excitation | Low spectral separation Δλ: 50 nm |
[18] |
BRET 1 4.1 | RLuc8 | 515 | TagRFP | 584 | CLZN v | Low spectral separation Δλ: 70 nm |
[18] | |
BRET 1 5 | RLuc8.6 | 535 | TagRFP | 584 | CLZN h | Increased stability and enhanced enzymatic activity of RLuc8.6 compared to RLuc8 | Low spectral separation Δλ: 50 nm |
[18] |
BRET 1 6 | RLuc8.6 | 535 | TurboFP | 635 | CLZN h | High spectral separation Δλ: 100 nm Application for BRET in living animals |
[18] | |
BRET 1 7 | Gluc | 470 | eYFP | 530 | CLZN h | Gluc smaller and brighter luciferase | Glu activity depends on pH and NaCl concentration Secreted luciferase |
[19,20] |
BRET 1 7.1 | hGluc | 470 | TdTomato | 580 | CLZN h | Large spectral separation compared to Gluc/eYFP pair Δλ: 110 nm High tolerance toward the solution components (serum) and pH. |
TdTomato: slow maturation processes compared to GFP Low stokes shift |
[21] |
BRET 1 7.2 | hGluc | 470 | DsRed | 583 | CLZN h | Large spectral separation: Δλ: 110 | DsRed: slow maturation processes, fluorescent intensity lower compared to GFP | [22] |
BRET 2 | RLuc | 395 | GFP2 | 510 | DeepBlueC | Large spectral separation: Δλ 115 for BRET2 vs. 50 for BRET1 1 | DeepBlue C: weak and short lasting light emission Necessity high expression of BRET partners |
[23] |
BRET 2 | RLuc2 | 420 | GFP2 | 510 | DeepBlueC | Working distance range increased (3.8–11.5 nm) compared to BRET 1 (2.2–6.6 nm) |
[13] | |
BRET 2 | RLucM/RLuc8 | 400 | GFP2 | 510 | DeepBlueC | RLuc8 increased stability and even higher quantum yield BRET signal 30 fold higher than RLuc/GFP2 pair Application for BRET in single live cells and living animals |
[24] | |
BRET 3 | FLuc | 565 | DsRed | 583 | D luciferin | DsRed: high photostability and resistance to pH; Application for in vivo imaging |
Overlap of donor/acceptor emission Low signal/noise |
[17,22] |
BRET 3 | FLuc | 565 | Cy3/Cy3.5 | 570/596 | D luciferin | Overlap of donor/acceptor emission Low signal/noise |
[25] | |
NanoBRET | Nluc | 462 | haloTag | 618 | Furimazine | NanoLuc is 100 fold brighter than RLuc. Furimazine permits longer observation (2 h compared to 25 min with coelenterazine) | Not red shifted version available Requires expensive Furimazine |
[26] |
NanoBRET | Nluc | 462 | Venus DsRed |
535 | Furimazine | Improved sensitivity and dynamic range Used as biosensor Single cell BRET imaging |
Not red shifted version available Requires expensive Furimazine |
[26] |
QD-BRET 1 | RLuc | 480 | Qdot | 620 | CLZN h | Used as biosensor Larger stokes shift Resistance to photobeaching Strong fluorescence |
[27] | |
QD-BRET 2 | RLuc8 | 480 | Qdot | 655 | CLZN h | Real time in vivo imaging | Size of Qdot | [28,29] |
QD-BRET 3 | FLuc | 565 | Qdot | 613/628 675 |
CLZN h | Working distance range increased | Problem for Coupling to proteins; cellular toxicity | [30,31] |
* Authors gave name for each system described. However, as no standard nomenclature has ever been established, these names are not absolute or exclusive, for reference only. § Peak wavelength in nm.